Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.
about
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
P2860
Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defining Clinical Exposures of ...... ciated with Improved Survival.
@en
type
label
Defining Clinical Exposures of ...... ciated with Improved Survival.
@en
prefLabel
Defining Clinical Exposures of ...... ciated with Improved Survival.
@en
P2093
P2860
P50
P356
P1476
Defining Clinical Exposures of ...... ociated with Improved Survival
@en
P2093
Anthony M Nicasio
David P Nicolau
Joseph L Kuti
Michael N Neely
Scott Van Wart
P2860
P304
P356
10.1128/AAC.01956-15
P407
P577
2015-12-14T00:00:00Z